Literature DB >> 33521852

Intestinal lysozyme releases Nod2 ligand(s) to promote the intestinal mucosal adjuvant activity of cholera toxin.

Haifang Wang1, Xueying Shen2,3, Xiaojiao Zheng2, Ying Pan2, Qin Zhang2, Zhihua Liu4.   

Abstract

Commensal bacteria boost serum IgG production in response to oral immunization with antigen and cholera toxin (CT) in a manner that depends on Nod2 (nucleotide-binding oligomerization domain-containing protein 2). In this study, we examined the role of intestinal lysozyme (Lyz1) in adjuvant activity of CT. We found that Lyz1 released Nod2 ligand(s) from bacteria. Lyz1 deficiency reduced the level of circulating Nod2 ligand in mice. Lyz1 deficiency also reduced the production of IgG and T-cellspecific cytokines after oral immunization in mice. Supplementing Lyz1-deficient mice with MDP restored IgG production. Furthermore, overexpression of Lyz1 in intestinal epithelium boosted the antigen-specific IgG response induced by CT. Collectively, our results indicate that Lyz1 plays an important role in mediating the immune regulatory effect of commensal bacteria through the release of Nod2 ligand(s).
© 2021. Science China Press and Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Nod2; Paneth cell; cholera toxin; lysozyme 1; muramyl dipeptide

Mesh:

Substances:

Year:  2021        PMID: 33521852     DOI: 10.1007/s11427-020-1862-8

Source DB:  PubMed          Journal:  Sci China Life Sci        ISSN: 1674-7305            Impact factor:   6.038


  45 in total

Review 1.  Transport of peptidomimetic drugs by the intestinal Di/tri-peptide transporter, PepT1.

Authors:  Birger Brodin; Carsten Uhd Nielsen; Bente Steffansen; Sven Frøkjaer
Journal:  Pharmacol Toxicol       Date:  2002-06

2.  Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax.

Authors:  Sandip K Datta; Mojgan Sabet; Kim Phung L Nguyen; Patricia A Valdez; Jose M Gonzalez-Navajas; Shamima Islam; Ivan Mihajlov; Joshua Fierer; Paul A Insel; Nicholas J Webster; Donald G Guiney; Eyal Raz
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity.

Authors:  Jörg H Fritz; Lionel Le Bourhis; Gernot Sellge; Joao Gamelas Magalhaes; Hafida Fsihi; Thomas A Kufer; Cathy Collins; Jérôme Viala; Richard L Ferrero; Stephen E Girardin; Dana J Philpott
Journal:  Immunity       Date:  2007-04-12       Impact factor: 31.745

4.  The mucosal adjuvanticity of cholera toxin involves enhancement of costimulatory activity by selective up-regulation of B7.2 expression.

Authors:  Y Cong; C T Weaver; C O Elson
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

5.  Antigen sampling by mucosal dendritic cells.

Authors:  Maria Foti; Paola Ricciardi-Castagnoli
Journal:  Trends Mol Med       Date:  2005-09       Impact factor: 11.951

Review 6.  NOD1 and NOD2: signaling, host defense, and inflammatory disease.

Authors:  Roberta Caruso; Neil Warner; Naohiro Inohara; Gabriel Núñez
Journal:  Immunity       Date:  2014-12-06       Impact factor: 31.745

7.  Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of S. pneumoniae colonization in mice.

Authors:  Kimberly M Davis; Shigeki Nakamura; Jeffrey N Weiser
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

8.  IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation.

Authors:  Danelle Eto; Christopher Lao; Daniel DiToro; Burton Barnett; Tania C Escobar; Robin Kageyama; Isharat Yusuf; Shane Crotty
Journal:  PLoS One       Date:  2011-03-14       Impact factor: 3.240

9.  Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity.

Authors:  Thomas B Clarke; Kimberly M Davis; Elena S Lysenko; Alice Y Zhou; Yimin Yu; Jeffrey N Weiser
Journal:  Nat Med       Date:  2010-01-17       Impact factor: 53.440

10.  Lactoferrin and lysozyme to reduce environmental enteric dysfunction and stunting in Malawian children: study protocol for a randomized controlled trial.

Authors:  William D Cheng; Karl J Wold; Nicole S Benzoni; Chrissie Thakwalakwa; Kenneth M Maleta; Mark J Manary; Indi Trehan
Journal:  Trials       Date:  2017-11-06       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.